

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcomere organization (GO:0045214) | 8.42961018 |
| 2 | muscle filament sliding (GO:0030049) | 7.89350794 |
| 3 | actin-myosin filament sliding (GO:0033275) | 7.89350794 |
| 4 | regulation of skeletal muscle contraction (GO:0014819) | 7.53380150 |
| 5 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 7.37687829 |
| 6 | cardiac myofibril assembly (GO:0055003) | 7.30923773 |
| 7 | myofibril assembly (GO:0030239) | 7.29864258 |
| 8 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 7.10447223 |
| 9 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 7.00048603 |
| 10 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.86219331 |
| 11 | actin-mediated cell contraction (GO:0070252) | 6.50337236 |
| 12 | tricarboxylic acid cycle (GO:0006099) | 6.31577117 |
| 13 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 6.24851183 |
| 14 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 6.02244500 |
| 15 | cardiac muscle contraction (GO:0060048) | 6.01681965 |
| 16 | plasma membrane repair (GO:0001778) | 6.01201180 |
| 17 | regulation of relaxation of muscle (GO:1901077) | 5.96260402 |
| 18 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.93579211 |
| 19 | regulation of cell communication by electrical coupling (GO:0010649) | 5.80138547 |
| 20 | regulation of actin filament-based movement (GO:1903115) | 5.71495947 |
| 21 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.71486290 |
| 22 | carnitine shuttle (GO:0006853) | 5.64247756 |
| 23 | striated muscle contraction (GO:0006941) | 5.59299360 |
| 24 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 5.46672538 |
| 25 | skeletal muscle contraction (GO:0003009) | 5.43623166 |
| 26 | actomyosin structure organization (GO:0031032) | 5.40900191 |
| 27 | cardiac muscle cell development (GO:0055013) | 5.34070118 |
| 28 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 5.32919567 |
| 29 | regulation of sarcomere organization (GO:0060297) | 5.08999926 |
| 30 | cardiac muscle hypertrophy (GO:0003300) | 5.04279680 |
| 31 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 5.03961051 |
| 32 | cardiac cell development (GO:0055006) | 4.98087180 |
| 33 | creatine metabolic process (GO:0006600) | 4.97484457 |
| 34 | regulation of cofactor metabolic process (GO:0051193) | 4.95818112 |
| 35 | regulation of coenzyme metabolic process (GO:0051196) | 4.95818112 |
| 36 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.94190166 |
| 37 | striated muscle hypertrophy (GO:0014897) | 4.87332561 |
| 38 | skeletal muscle adaptation (GO:0043501) | 4.86906336 |
| 39 | fatty acid transmembrane transport (GO:1902001) | 4.86464031 |
| 40 | actin filament-based movement (GO:0030048) | 4.82642399 |
| 41 | regulation of striated muscle contraction (GO:0006942) | 4.68436079 |
| 42 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.68009763 |
| 43 | heart process (GO:0003015) | 4.64127220 |
| 44 | heart contraction (GO:0060047) | 4.64127220 |
| 45 | cardiac muscle tissue morphogenesis (GO:0055008) | 4.51596971 |
| 46 | skeletal muscle fiber development (GO:0048741) | 4.46471867 |
| 47 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 4.42686897 |
| 48 | adult heart development (GO:0007512) | 4.41813333 |
| 49 | muscle fiber development (GO:0048747) | 4.41555846 |
| 50 | myotube cell development (GO:0014904) | 4.36989549 |
| 51 | regulation of membrane repolarization (GO:0060306) | 4.33017790 |
| 52 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.30375065 |
| 53 | muscle hypertrophy (GO:0014896) | 4.29956054 |
| 54 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.22143656 |
| 55 | carnitine transmembrane transport (GO:1902603) | 4.19103468 |
| 56 | heart trabecula formation (GO:0060347) | 4.16498891 |
| 57 | muscle tissue morphogenesis (GO:0060415) | 4.14057676 |
| 58 | NADH metabolic process (GO:0006734) | 4.13431745 |
| 59 | striated muscle adaptation (GO:0014888) | 4.10882760 |
| 60 | muscle contraction (GO:0006936) | 4.04468055 |
| 61 | regulation of sulfur metabolic process (GO:0042762) | 4.03347084 |
| 62 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 4.02366257 |
| 63 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 3.93992551 |
| 64 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.92569959 |
| 65 | muscle hypertrophy in response to stress (GO:0003299) | 3.92569959 |
| 66 | cardiac muscle adaptation (GO:0014887) | 3.92569959 |
| 67 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.91305879 |
| 68 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.91097653 |
| 69 | 2-oxoglutarate metabolic process (GO:0006103) | 3.90239350 |
| 70 | respiratory electron transport chain (GO:0022904) | 3.89729212 |
| 71 | response to inactivity (GO:0014854) | 3.87440789 |
| 72 | glycogen catabolic process (GO:0005980) | 3.87201711 |
| 73 | glucan biosynthetic process (GO:0009250) | 3.83079757 |
| 74 | amino-acid betaine transport (GO:0015838) | 3.82772494 |
| 75 | carnitine transport (GO:0015879) | 3.82772494 |
| 76 | skeletal muscle tissue development (GO:0007519) | 3.82663461 |
| 77 | electron transport chain (GO:0022900) | 3.79323641 |
| 78 | muscle system process (GO:0003012) | 3.78326708 |
| 79 | cell communication involved in cardiac conduction (GO:0086065) | 3.77902147 |
| 80 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.76701603 |
| 81 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.74945158 |
| 82 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.74945158 |
| 83 | striated muscle atrophy (GO:0014891) | 3.73507751 |
| 84 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.72961470 |
| 85 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.72037779 |
| 86 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.72037779 |
| 87 | oxidative phosphorylation (GO:0006119) | 3.71451680 |
| 88 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.67807397 |
| 89 | regulation of sequestering of triglyceride (GO:0010889) | 3.65323321 |
| 90 | response to muscle activity (GO:0014850) | 3.64695970 |
| 91 | regulation of cardiac muscle contraction (GO:0055117) | 3.62816761 |
| 92 | regulation of the force of heart contraction (GO:0002026) | 3.61619633 |
| 93 | glucan catabolic process (GO:0009251) | 3.61242017 |
| 94 | muscle atrophy (GO:0014889) | 3.59749254 |
| 95 | positive regulation of cation channel activity (GO:2001259) | 3.59544742 |
| 96 | relaxation of cardiac muscle (GO:0055119) | 3.57269548 |
| 97 | striated muscle cell development (GO:0055002) | 3.56796080 |
| 98 | cardiac muscle cell action potential (GO:0086001) | 3.55920832 |
| 99 | muscle cell cellular homeostasis (GO:0046716) | 3.55672737 |
| 100 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.55556817 |
| 101 | response to caffeine (GO:0031000) | 3.54333426 |
| 102 | regulation of ATPase activity (GO:0043462) | 3.53954125 |
| 103 | regulation of ATP catabolic process (GO:1903289) | 3.53954125 |
| 104 | negative regulation of potassium ion transport (GO:0043267) | 3.50860583 |
| 105 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.50725120 |
| 106 | ATP synthesis coupled proton transport (GO:0015986) | 3.50725120 |
| 107 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.50422679 |
| 108 | muscle adaptation (GO:0043500) | 3.47447110 |
| 109 | cytidine metabolic process (GO:0046087) | 3.47056709 |
| 110 | cytidine catabolic process (GO:0006216) | 3.47056709 |
| 111 | cytidine deamination (GO:0009972) | 3.47056709 |
| 112 | succinate metabolic process (GO:0006105) | 3.45034736 |
| 113 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.44169674 |
| 114 | ubiquinone biosynthetic process (GO:0006744) | 3.43423191 |
| 115 | regulation of heart rate (GO:0002027) | 3.40533621 |
| 116 | skeletal muscle tissue regeneration (GO:0043403) | 3.39605716 |
| 117 | cellular polysaccharide catabolic process (GO:0044247) | 3.39539778 |
| 118 | glycogen biosynthetic process (GO:0005978) | 3.36347361 |
| 119 | polysaccharide catabolic process (GO:0000272) | 3.27973738 |
| 120 | regulation of muscle system process (GO:0090257) | 3.23750556 |
| 121 | muscle structure development (GO:0061061) | 3.21477292 |
| 122 | regulation of muscle contraction (GO:0006937) | 3.19782759 |
| 123 | muscle organ development (GO:0007517) | 3.17033381 |
| 124 | glycogen metabolic process (GO:0005977) | 3.11556363 |
| 125 | relaxation of muscle (GO:0090075) | 3.10029588 |
| 126 | ubiquinone metabolic process (GO:0006743) | 3.09220303 |
| 127 | muscle cell development (GO:0055001) | 3.08876987 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.83795435 |
| 2 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 4.22970646 |
| 3 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 4.16569311 |
| 4 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.79473763 |
| 5 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 3.61336834 |
| 6 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 3.61336834 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.22740234 |
| 8 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.00446753 |
| 9 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.93379054 |
| 10 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.66699194 |
| 11 | GATA1_22025678_ChIP-Seq_K562_Human | 2.61127376 |
| 12 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.49730735 |
| 13 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.46205108 |
| 14 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.44565876 |
| 15 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.43410404 |
| 16 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.31699273 |
| 17 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.22021129 |
| 18 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.18986584 |
| 19 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.14924744 |
| 20 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 2.05135291 |
| 21 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.96376095 |
| 22 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.94930346 |
| 23 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.93665826 |
| 24 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.81844277 |
| 25 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.77599895 |
| 26 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.77494946 |
| 27 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.68893532 |
| 28 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.64856618 |
| 29 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.63082080 |
| 30 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.57552178 |
| 31 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.53969347 |
| 32 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.50899331 |
| 33 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.47789876 |
| 34 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.47766662 |
| 35 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.45079326 |
| 36 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.44738158 |
| 37 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.41638045 |
| 38 | FUS_26573619_Chip-Seq_HEK293_Human | 1.41486158 |
| 39 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.41060257 |
| 40 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.39791115 |
| 41 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.39135586 |
| 42 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.38914610 |
| 43 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.38835632 |
| 44 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.38289472 |
| 45 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.33804412 |
| 46 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.32399212 |
| 47 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.32167754 |
| 48 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.32111733 |
| 49 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.27666227 |
| 50 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.26954101 |
| 51 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.26823191 |
| 52 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.26789432 |
| 53 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.25801528 |
| 54 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.25561479 |
| 55 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.25152384 |
| 56 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.24793861 |
| 57 | TCF4_23295773_ChIP-Seq_U87_Human | 1.24199305 |
| 58 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.23839811 |
| 59 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.23839811 |
| 60 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.23013704 |
| 61 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.21562160 |
| 62 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.21081739 |
| 63 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.17926502 |
| 64 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.17394758 |
| 65 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.16782396 |
| 66 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.16289638 |
| 67 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.15916537 |
| 68 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.15888161 |
| 69 | STAT3_23295773_ChIP-Seq_U87_Human | 1.15567093 |
| 70 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.15185564 |
| 71 | P300_19829295_ChIP-Seq_ESCs_Human | 1.15144759 |
| 72 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.14621475 |
| 73 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.14209008 |
| 74 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.12581441 |
| 75 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.12414166 |
| 76 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.10936285 |
| 77 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.10886239 |
| 78 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.10083500 |
| 79 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.09234561 |
| 80 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.07888604 |
| 81 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.07703538 |
| 82 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.07648521 |
| 83 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.07590053 |
| 84 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.06523756 |
| 85 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.05852827 |
| 86 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.04395023 |
| 87 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.04349871 |
| 88 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.02392543 |
| 89 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.02283835 |
| 90 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.01379661 |
| 91 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.01154977 |
| 92 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.00860359 |
| 93 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.00571526 |
| 94 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.00402086 |
| 95 | AR_25329375_ChIP-Seq_VCAP_Human | 0.99902448 |
| 96 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.98629128 |
| 97 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.98454028 |
| 98 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.98277596 |
| 99 | VDR_22108803_ChIP-Seq_LS180_Human | 0.97953477 |
| 100 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.97001889 |
| 101 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.96514147 |
| 102 | NFYB_21822215_ChIP-Seq_K562_Human | 0.96210896 |
| 103 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.96104852 |
| 104 | TBL1_22424771_ChIP-Seq_293T_Human | 0.95757103 |
| 105 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.95221751 |
| 106 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.94693039 |
| 107 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.94572120 |
| 108 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.94363148 |
| 109 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.94363148 |
| 110 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.93368256 |
| 111 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93028506 |
| 112 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.91352787 |
| 113 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.91350050 |
| 114 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.91319112 |
| 115 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.90394008 |
| 116 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.89988114 |
| 117 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.89556362 |
| 118 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.89033701 |
| 119 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.89025570 |
| 120 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.89021021 |
| 121 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.88864753 |
| 122 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.88856394 |
| 123 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.87822439 |
| 124 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.87310695 |
| 125 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.86711352 |
| 126 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.84673767 |
| 127 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.84268153 |
| 128 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.83452546 |
| 129 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.83059599 |
| 130 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.82032708 |
| 131 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.80984673 |
| 132 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.80984673 |
| 133 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.80600749 |
| 134 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.79016467 |
| 135 | CJUN_26792858_Chip-Seq_BT549_Human | 0.78793720 |
| 136 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.78229297 |
| 137 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.78180451 |
| 138 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.77336078 |
| 139 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.76877904 |
| 140 | GATA1_19941826_ChIP-Seq_K562_Human | 0.76292813 |
| 141 | CBP_21632823_ChIP-Seq_H3396_Human | 0.75842584 |
| 142 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.75356330 |
| 143 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.74729595 |
| 144 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.74344691 |
| 145 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.74103257 |
| 146 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.73045839 |
| 147 | P68_20966046_ChIP-Seq_HELA_Human | 0.72728169 |
| 148 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.71878823 |
| 149 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.71548634 |
| 150 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.70823584 |
| 151 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.70615896 |
| 152 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.69764005 |
| 153 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.69444924 |
| 154 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.69444924 |
| 155 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.69148243 |
| 156 | ATF3_27146783_Chip-Seq_COLON_Human | 0.68675119 |
| 157 | GATA2_19941826_ChIP-Seq_K562_Human | 0.68601541 |
| 158 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.68316122 |
| 159 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.68158932 |
| 160 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.67907920 |
| 161 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.67795456 |
| 162 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.67083235 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 6.69380439 |
| 2 | MP0003646_muscle_fatigue | 6.28253009 |
| 3 | MP0000751_myopathy | 5.40012929 |
| 4 | MP0004084_abnormal_cardiac_muscle | 4.67923201 |
| 5 | MP0000749_muscle_degeneration | 4.63724384 |
| 6 | MP0004036_abnormal_muscle_relaxation | 4.31642115 |
| 7 | MP0004215_abnormal_myocardial_fiber | 4.10272818 |
| 8 | MP0004145_abnormal_muscle_electrophysio | 4.02212995 |
| 9 | MP0005330_cardiomyopathy | 3.44595279 |
| 10 | MP0004087_abnormal_muscle_fiber | 3.21295829 |
| 11 | MP0004130_abnormal_muscle_cell | 3.18761691 |
| 12 | MP0002106_abnormal_muscle_physiology | 3.07061796 |
| 13 | MP0005620_abnormal_muscle_contractility | 2.91611609 |
| 14 | MP0000750_abnormal_muscle_regeneration | 2.88919826 |
| 15 | MP0002269_muscular_atrophy | 2.72409743 |
| 16 | MP0002972_abnormal_cardiac_muscle | 2.71799576 |
| 17 | MP0000747_muscle_weakness | 2.65181039 |
| 18 | MP0000759_abnormal_skeletal_muscle | 2.52336410 |
| 19 | MP0005369_muscle_phenotype | 2.50523633 |
| 20 | MP0003137_abnormal_impulse_conducting | 2.46156126 |
| 21 | MP0008775_abnormal_heart_ventricle | 2.42902007 |
| 22 | MP0004484_altered_response_of | 2.41241307 |
| 23 | MP0005385_cardiovascular_system_phenoty | 2.23457097 |
| 24 | MP0001544_abnormal_cardiovascular_syste | 2.23457097 |
| 25 | MP0010630_abnormal_cardiac_muscle | 2.20629482 |
| 26 | MP0006036_abnormal_mitochondrial_physio | 2.01835658 |
| 27 | MP0004233_abnormal_muscle_weight | 1.98447345 |
| 28 | MP0006138_congestive_heart_failure | 1.86016904 |
| 29 | MP0003221_abnormal_cardiomyocyte_apopto | 1.81293778 |
| 30 | MP0004085_abnormal_heartbeat | 1.76392348 |
| 31 | MP0002332_abnormal_exercise_endurance | 1.69555552 |
| 32 | MP0003828_pulmonary_edema | 1.65983864 |
| 33 | MP0005666_abnormal_adipose_tissue | 1.57929882 |
| 34 | MP0004510_myositis | 1.45805110 |
| 35 | MP0004185_abnormal_adipocyte_glucose | 1.38679171 |
| 36 | MP0002127_abnormal_cardiovascular_syste | 1.38339163 |
| 37 | MP0000372_irregular_coat_pigmentation | 1.29126939 |
| 38 | MP0003950_abnormal_plasma_membrane | 1.21060314 |
| 39 | MP0005670_abnormal_white_adipose | 1.18972189 |
| 40 | MP0006035_abnormal_mitochondrial_morpho | 1.13402591 |
| 41 | MP0002108_abnormal_muscle_morphology | 1.13241698 |
| 42 | MP0004043_abnormal_pH_regulation | 1.10652800 |
| 43 | MP0001661_extended_life_span | 1.10126484 |
| 44 | MP0005375_adipose_tissue_phenotype | 1.10117752 |
| 45 | MP0002234_abnormal_pharynx_morphology | 1.07120113 |
| 46 | MP0000343_altered_response_to | 1.02258410 |
| 47 | MP0000266_abnormal_heart_morphology | 0.95184471 |
| 48 | MP0003567_abnormal_fetal_cardiomyocyte | 0.92358526 |
| 49 | MP0005165_increased_susceptibility_to | 0.91575193 |
| 50 | MP0002638_abnormal_pupillary_reflex | 0.90494701 |
| 51 | MP0005266_abnormal_metabolism | 0.88563689 |
| 52 | MP0002971_abnormal_brown_adipose | 0.84844277 |
| 53 | MP0000733_abnormal_muscle_development | 0.83341547 |
| 54 | MP0000013_abnormal_adipose_tissue | 0.82060591 |
| 55 | MP0009780_abnormal_chondrocyte_physiolo | 0.80654623 |
| 56 | MP0000230_abnormal_systemic_arterial | 0.79983407 |
| 57 | MP0004147_increased_porphyrin_level | 0.78924116 |
| 58 | MP0002078_abnormal_glucose_homeostasis | 0.75195512 |
| 59 | MP0002909_abnormal_adrenal_gland | 0.75007329 |
| 60 | MP0004142_abnormal_muscle_tone | 0.73150256 |
| 61 | MP0000003_abnormal_adipose_tissue | 0.68677316 |
| 62 | MP0005645_abnormal_hypothalamus_physiol | 0.61230381 |
| 63 | MP0005535_abnormal_body_temperature | 0.59781814 |
| 64 | MP0005451_abnormal_body_composition | 0.59442985 |
| 65 | MP0002822_catalepsy | 0.58982052 |
| 66 | MP0008961_abnormal_basal_metabolism | 0.57312079 |
| 67 | MP0003806_abnormal_nucleotide_metabolis | 0.57199663 |
| 68 | MP0001984_abnormal_olfaction | 0.55706817 |
| 69 | MP0002876_abnormal_thyroid_physiology | 0.52622854 |
| 70 | MP0002128_abnormal_blood_circulation | 0.51995590 |
| 71 | MP0003279_aneurysm | 0.50096868 |
| 72 | MP0005334_abnormal_fat_pad | 0.48713269 |
| 73 | MP0006276_abnormal_autonomic_nervous | 0.47962646 |
| 74 | MP0003195_calcinosis | 0.47686586 |
| 75 | MP0005332_abnormal_amino_acid | 0.47265984 |
| 76 | MP0005319_abnormal_enzyme/_coenzyme | 0.45859651 |
| 77 | MP0010368_abnormal_lymphatic_system | 0.44809367 |
| 78 | MP0003045_fibrosis | 0.44448963 |
| 79 | MP0002272_abnormal_nervous_system | 0.44009684 |
| 80 | MP0004134_abnormal_chest_morphology | 0.43470703 |
| 81 | MP0001501_abnormal_sleep_pattern | 0.43348831 |
| 82 | MP0005187_abnormal_penis_morphology | 0.43149067 |
| 83 | MP0009745_abnormal_behavioral_response | 0.42811705 |
| 84 | MP0005083_abnormal_biliary_tract | 0.42638890 |
| 85 | MP0003136_yellow_coat_color | 0.41831446 |
| 86 | MP0009046_muscle_twitch | 0.39819959 |
| 87 | MP0005423_abnormal_somatic_nervous | 0.39648377 |
| 88 | MP0003705_abnormal_hypodermis_morpholog | 0.39207375 |
| 89 | MP0001879_abnormal_lymphatic_vessel | 0.36961324 |
| 90 | MP0002118_abnormal_lipid_homeostasis | 0.36678819 |
| 91 | MP0002067_abnormal_sensory_capabilities | 0.35804256 |
| 92 | MP0008569_lethality_at_weaning | 0.35386473 |
| 93 | MP0002734_abnormal_mechanical_nocicepti | 0.34045101 |
| 94 | MP0001986_abnormal_taste_sensitivity | 0.33743369 |
| 95 | MP0003879_abnormal_hair_cell | 0.33497954 |
| 96 | MP0005452_abnormal_adipose_tissue | 0.33331721 |
| 97 | MP0001486_abnormal_startle_reflex | 0.33127580 |
| 98 | MP0002877_abnormal_melanocyte_morpholog | 0.33015346 |
| 99 | MP0002693_abnormal_pancreas_physiology | 0.32988013 |
| 100 | MP0005171_absent_coat_pigmentation | 0.32780550 |
| 101 | MP0003656_abnormal_erythrocyte_physiolo | 0.32744512 |
| 102 | MP0005386_behavior/neurological_phenoty | 0.32674372 |
| 103 | MP0004924_abnormal_behavior | 0.32674372 |
| 104 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.32669831 |
| 105 | MP0005253_abnormal_eye_physiology | 0.32423469 |
| 106 | MP0003566_abnormal_cell_adhesion | 0.31497253 |
| 107 | MP0000569_abnormal_digit_pigmentation | 0.30941334 |
| 108 | MP0005551_abnormal_eye_electrophysiolog | 0.30480340 |
| 109 | MP0003948_abnormal_gas_homeostasis | 0.29604399 |
| 110 | MP0001502_abnormal_circadian_rhythm | 0.29534599 |
| 111 | MP0005623_abnormal_meninges_morphology | 0.29219224 |
| 112 | MP0002066_abnormal_motor_capabilities/c | 0.28698188 |
| 113 | MP0004270_analgesia | 0.28098937 |
| 114 | MP0001440_abnormal_grooming_behavior | 0.26768591 |
| 115 | MP0000767_abnormal_smooth_muscle | 0.26652339 |
| 116 | MP0001765_abnormal_ion_homeostasis | 0.26618925 |
| 117 | MP0005275_abnormal_skin_tensile | 0.26561202 |
| 118 | MP0001485_abnormal_pinna_reflex | 0.25515491 |
| 119 | MP0002925_abnormal_cardiovascular_devel | 0.24039839 |
| 120 | MP0005448_abnormal_energy_balance | 0.22907426 |
| 121 | MP0001299_abnormal_eye_distance/ | 0.22721295 |
| 122 | MP0003959_abnormal_lean_body | 0.22668339 |
| 123 | MP0009115_abnormal_fat_cell | 0.22373948 |
| 124 | MP0001727_abnormal_embryo_implantation | 0.21671646 |
| 125 | MP0005167_abnormal_blood-brain_barrier | 0.21663299 |
| 126 | MP0003953_abnormal_hormone_level | 0.20509262 |
| 127 | MP0002896_abnormal_bone_mineralization | 0.18736704 |
| 128 | MP0005376_homeostasis/metabolism_phenot | 0.18349110 |
| 129 | MP0005085_abnormal_gallbladder_physiolo | 0.17689795 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced myalgia (HP:0003738) | 7.49958786 |
| 2 | Exercise-induced muscle cramps (HP:0003710) | 7.07590723 |
| 3 | Calf muscle hypertrophy (HP:0008981) | 6.84135140 |
| 4 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.80579120 |
| 5 | Sudden death (HP:0001699) | 6.58374531 |
| 6 | Myoglobinuria (HP:0002913) | 5.76403381 |
| 7 | Muscle fiber splitting (HP:0003555) | 5.66699734 |
| 8 | Ventricular tachycardia (HP:0004756) | 5.56241788 |
| 9 | Abnormality of the calf musculature (HP:0001430) | 5.19999708 |
| 10 | Hyporeflexia of lower limbs (HP:0002600) | 5.17195935 |
| 11 | Muscle fiber inclusion bodies (HP:0100299) | 5.05491231 |
| 12 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.89088666 |
| 13 | Atrial fibrillation (HP:0005110) | 4.76433910 |
| 14 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.63754007 |
| 15 | Subaortic stenosis (HP:0001682) | 4.63754007 |
| 16 | Primary atrial arrhythmia (HP:0001692) | 4.45416276 |
| 17 | Rhabdomyolysis (HP:0003201) | 4.44758357 |
| 18 | EMG: myopathic abnormalities (HP:0003458) | 4.42089209 |
| 19 | Difficulty running (HP:0009046) | 4.36913780 |
| 20 | Lipoatrophy (HP:0100578) | 4.30720019 |
| 21 | Supraventricular tachycardia (HP:0004755) | 4.29298893 |
| 22 | Supraventricular arrhythmia (HP:0005115) | 4.18909839 |
| 23 | Nemaline bodies (HP:0003798) | 4.17195234 |
| 24 | Increased connective tissue (HP:0009025) | 4.12434623 |
| 25 | Myotonia (HP:0002486) | 3.94172553 |
| 26 | Type 1 muscle fiber predominance (HP:0003803) | 3.88639938 |
| 27 | Right ventricular cardiomyopathy (HP:0011663) | 3.87356043 |
| 28 | Asymmetric septal hypertrophy (HP:0001670) | 3.86439138 |
| 29 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.86322635 |
| 30 | Bundle branch block (HP:0011710) | 3.84945869 |
| 31 | Syncope (HP:0001279) | 3.77761292 |
| 32 | Dilated cardiomyopathy (HP:0001644) | 3.73008568 |
| 33 | Palpitations (HP:0001962) | 3.67275112 |
| 34 | Muscle stiffness (HP:0003552) | 3.59907089 |
| 35 | Prolonged QT interval (HP:0001657) | 3.48294938 |
| 36 | Ventricular arrhythmia (HP:0004308) | 3.21562043 |
| 37 | Heart block (HP:0012722) | 3.17657605 |
| 38 | Myopathic facies (HP:0002058) | 3.12003531 |
| 39 | Difficulty climbing stairs (HP:0003551) | 3.11597853 |
| 40 | Distal arthrogryposis (HP:0005684) | 3.07945040 |
| 41 | Calcaneovalgus deformity (HP:0001848) | 3.04221368 |
| 42 | Abnormal atrioventricular conduction (HP:0005150) | 2.98690023 |
| 43 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.97770426 |
| 44 | Acute necrotizing encephalopathy (HP:0006965) | 2.92680608 |
| 45 | Increased variability in muscle fiber diameter (HP:0003557) | 2.91962362 |
| 46 | Areflexia of lower limbs (HP:0002522) | 2.91832700 |
| 47 | Distal lower limb muscle weakness (HP:0009053) | 2.90449134 |
| 48 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.87857401 |
| 49 | Atrioventricular block (HP:0001678) | 2.86770635 |
| 50 | Neck muscle weakness (HP:0000467) | 2.79707316 |
| 51 | Hepatic necrosis (HP:0002605) | 2.79176810 |
| 52 | Rimmed vacuoles (HP:0003805) | 2.74138315 |
| 53 | Deformed tarsal bones (HP:0008119) | 2.74030829 |
| 54 | Round ear (HP:0100830) | 2.73516167 |
| 55 | Ketoacidosis (HP:0001993) | 2.73118990 |
| 56 | Ventricular fibrillation (HP:0001663) | 2.70165526 |
| 57 | Abnormal finger flexion creases (HP:0006143) | 2.67725920 |
| 58 | Left ventricular hypertrophy (HP:0001712) | 2.62081271 |
| 59 | Malignant hyperthermia (HP:0002047) | 2.57911878 |
| 60 | Abnormal EKG (HP:0003115) | 2.55298360 |
| 61 | Acute encephalopathy (HP:0006846) | 2.53940410 |
| 62 | Ulnar deviation of the wrist (HP:0003049) | 2.51103600 |
| 63 | Hypoglycemic coma (HP:0001325) | 2.49298969 |
| 64 | Progressive macrocephaly (HP:0004481) | 2.46310409 |
| 65 | Hepatocellular necrosis (HP:0001404) | 2.42651148 |
| 66 | Limb-girdle muscle atrophy (HP:0003797) | 2.38565528 |
| 67 | Abnormality of alanine metabolism (HP:0010916) | 2.34713519 |
| 68 | Hyperalaninemia (HP:0003348) | 2.34713519 |
| 69 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.34713519 |
| 70 | Mitochondrial inheritance (HP:0001427) | 2.28284120 |
| 71 | Increased muscle lipid content (HP:0009058) | 2.28084532 |
| 72 | Exercise intolerance (HP:0003546) | 2.27899953 |
| 73 | Bulbar palsy (HP:0001283) | 2.27358966 |
| 74 | Distal lower limb amyotrophy (HP:0008944) | 2.26827006 |
| 75 | Hypoplastic ischia (HP:0003175) | 2.23167362 |
| 76 | Cerebral edema (HP:0002181) | 2.22032547 |
| 77 | Muscular dystrophy (HP:0003560) | 2.21410377 |
| 78 | Testicular atrophy (HP:0000029) | 2.21020438 |
| 79 | Fetal akinesia sequence (HP:0001989) | 2.20311459 |
| 80 | EMG: neuropathic changes (HP:0003445) | 2.18169759 |
| 81 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.17108810 |
| 82 | Dicarboxylic aciduria (HP:0003215) | 2.17108810 |
| 83 | Increased CSF lactate (HP:0002490) | 2.15359576 |
| 84 | Weak cry (HP:0001612) | 2.13370442 |
| 85 | Facial diplegia (HP:0001349) | 2.13143878 |
| 86 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.11326470 |
| 87 | Palmoplantar keratoderma (HP:0000982) | 2.11100221 |
| 88 | Fatigable weakness (HP:0003473) | 2.09451423 |
| 89 | Abnormality of the neuromuscular junction (HP:0003398) | 2.09451423 |
| 90 | Slender build (HP:0001533) | 2.08731638 |
| 91 | Abnormality of the foot musculature (HP:0001436) | 2.06020490 |
| 92 | Proximal amyotrophy (HP:0007126) | 2.05417944 |
| 93 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.03739525 |
| 94 | Large for gestational age (HP:0001520) | 2.03239857 |
| 95 | Lactic acidosis (HP:0003128) | 2.02774379 |
| 96 | Increased intramyocellular lipid droplets (HP:0012240) | 2.01300009 |
| 97 | Conjunctival hamartoma (HP:0100780) | 2.01165568 |
| 98 | Gowers sign (HP:0003391) | 1.99349185 |
| 99 | Ketosis (HP:0001946) | 1.99301228 |
| 100 | Generalized muscle weakness (HP:0003324) | 1.96771375 |
| 101 | Abnormality of the ischium (HP:0003174) | 1.95329513 |
| 102 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.94249939 |
| 103 | Waddling gait (HP:0002515) | 1.93810249 |
| 104 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.93162276 |
| 105 | Frequent falls (HP:0002359) | 1.92584094 |
| 106 | Hyperkalemia (HP:0002153) | 1.91738382 |
| 107 | Progressive muscle weakness (HP:0003323) | 1.89426220 |
| 108 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.88906953 |
| 109 | Pheochromocytoma (HP:0002666) | 1.87250628 |
| 110 | Respiratory failure (HP:0002878) | 1.87008287 |
| 111 | Hip contracture (HP:0003273) | 1.85839825 |
| 112 | Hyperglycemia (HP:0003074) | 1.85562110 |
| 113 | Ragged-red muscle fibers (HP:0003200) | 1.85329184 |
| 114 | Scapular winging (HP:0003691) | 1.84083068 |
| 115 | Central scotoma (HP:0000603) | 1.83889887 |
| 116 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.82093142 |
| 117 | Absent phalangeal crease (HP:0006109) | 1.81405203 |
| 118 | Foot dorsiflexor weakness (HP:0009027) | 1.80863115 |
| 119 | Type 2 muscle fiber atrophy (HP:0003554) | 1.65675755 |
| 120 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.64539595 |
| 121 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.64539595 |
| 122 | Oligomenorrhea (HP:0000876) | 1.64284049 |
| 123 | Spinal rigidity (HP:0003306) | 1.61769045 |
| 124 | Steppage gait (HP:0003376) | 1.60137331 |
| 125 | Nonprogressive disorder (HP:0003680) | 1.57199775 |
| 126 | Long clavicles (HP:0000890) | 1.56786576 |
| 127 | Shoulder girdle muscle weakness (HP:0003547) | 1.55345939 |
| 128 | Pelvic girdle muscle weakness (HP:0003749) | 1.49270266 |
| 129 | Lower limb amyotrophy (HP:0007210) | 1.47690470 |
| 130 | Limb-girdle muscle weakness (HP:0003325) | 1.45556201 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 6.56112618 |
| 2 | OBSCN | 5.37488131 |
| 3 | PHKG1 | 4.90966160 |
| 4 | PHKG2 | 4.90966160 |
| 5 | PDK3 | 3.46330020 |
| 6 | PDK4 | 3.46330020 |
| 7 | LMTK2 | 2.77582241 |
| 8 | BCKDK | 2.67052102 |
| 9 | DMPK | 2.61606018 |
| 10 | PINK1 | 2.45638809 |
| 11 | MYLK | 2.45330496 |
| 12 | TRIB3 | 2.43586707 |
| 13 | NEK1 | 2.38076134 |
| 14 | PKN2 | 2.35481595 |
| 15 | PIK3CA | 2.24578899 |
| 16 | PDK2 | 2.17049849 |
| 17 | NME1 | 2.03782359 |
| 18 | MUSK | 1.90051797 |
| 19 | STK24 | 1.62187354 |
| 20 | MARK1 | 1.53796236 |
| 21 | MAP3K7 | 1.48883615 |
| 22 | TIE1 | 1.48356424 |
| 23 | MAP2K3 | 1.43555111 |
| 24 | INSRR | 1.42643269 |
| 25 | FRK | 1.32514143 |
| 26 | GRK7 | 1.30294406 |
| 27 | MAPK12 | 1.28095266 |
| 28 | PIK3CG | 1.19623231 |
| 29 | CAMK2D | 1.06834584 |
| 30 | LIMK1 | 1.05499633 |
| 31 | PRKD1 | 0.97878887 |
| 32 | PRKAA1 | 0.97107261 |
| 33 | PRKAA2 | 0.95193169 |
| 34 | MAP2K4 | 0.88279636 |
| 35 | PAK3 | 0.84781708 |
| 36 | TRPM7 | 0.82861733 |
| 37 | CCNB1 | 0.82205591 |
| 38 | FLT3 | 0.79339155 |
| 39 | ILK | 0.78775438 |
| 40 | ZAK | 0.77130768 |
| 41 | RIPK1 | 0.76910793 |
| 42 | MAP4K2 | 0.75504057 |
| 43 | MAPKAPK3 | 0.74971652 |
| 44 | CDC42BPA | 0.73762077 |
| 45 | DAPK2 | 0.73119455 |
| 46 | MAPK13 | 0.72321318 |
| 47 | CAMK4 | 0.72310081 |
| 48 | BMPR1B | 0.71502524 |
| 49 | WNK4 | 0.65955628 |
| 50 | MAP3K3 | 0.63833209 |
| 51 | ROCK1 | 0.62884136 |
| 52 | MAP3K5 | 0.61817478 |
| 53 | PKN1 | 0.59932731 |
| 54 | CAMK2A | 0.57668749 |
| 55 | NEK9 | 0.56786265 |
| 56 | STK38L | 0.53891423 |
| 57 | MAP2K1 | 0.53644485 |
| 58 | TNIK | 0.52942267 |
| 59 | CAMK2G | 0.50082067 |
| 60 | MAP2K6 | 0.47942932 |
| 61 | ADRBK2 | 0.46246620 |
| 62 | PDGFRA | 0.45732803 |
| 63 | MAPK4 | 0.44965968 |
| 64 | CAMK1 | 0.44683767 |
| 65 | TAOK2 | 0.44436821 |
| 66 | STK38 | 0.43850897 |
| 67 | PDPK1 | 0.43297803 |
| 68 | PRKACB | 0.42960048 |
| 69 | PRKACA | 0.41753855 |
| 70 | OXSR1 | 0.41345873 |
| 71 | DAPK3 | 0.41294597 |
| 72 | MAP3K4 | 0.41104803 |
| 73 | WNK1 | 0.40809267 |
| 74 | STK4 | 0.39327161 |
| 75 | ACVR1B | 0.38986884 |
| 76 | PRKD3 | 0.38501502 |
| 77 | PDK1 | 0.37935351 |
| 78 | WNK3 | 0.36883397 |
| 79 | CASK | 0.36513823 |
| 80 | SGK1 | 0.36016223 |
| 81 | STK11 | 0.35856986 |
| 82 | SGK3 | 0.35813684 |
| 83 | RPS6KL1 | 0.34750165 |
| 84 | RPS6KC1 | 0.34750165 |
| 85 | PRKACG | 0.34530664 |
| 86 | EPHB1 | 0.34251153 |
| 87 | PTK2B | 0.34132705 |
| 88 | GRK1 | 0.33847522 |
| 89 | PRKCE | 0.33513139 |
| 90 | AKT2 | 0.30681411 |
| 91 | NLK | 0.28480053 |
| 92 | ROCK2 | 0.27894059 |
| 93 | MAP3K6 | 0.26801584 |
| 94 | PRKCH | 0.26552333 |
| 95 | RPS6KA6 | 0.26148632 |
| 96 | ADRBK1 | 0.25882197 |
| 97 | MAPK11 | 0.25719937 |
| 98 | MAPK7 | 0.25574407 |
| 99 | TGFBR2 | 0.25119160 |
| 100 | SGK2 | 0.24776303 |
| 101 | PTK6 | 0.24557395 |
| 102 | RET | 0.23873440 |
| 103 | PRKG1 | 0.23564879 |
| 104 | CAMKK2 | 0.23378686 |
| 105 | DYRK1B | 0.23280389 |
| 106 | RPS6KB1 | 0.22697384 |
| 107 | RPS6KA3 | 0.21282080 |
| 108 | MAP3K1 | 0.20665131 |
| 109 | TAOK1 | 0.20111530 |
| 110 | EEF2K | 0.18858001 |
| 111 | SIK1 | 0.18497249 |
| 112 | MOS | 0.18208460 |
| 113 | RPS6KA1 | 0.17883062 |
| 114 | SGK494 | 0.17561809 |
| 115 | SGK223 | 0.17561809 |
| 116 | LATS1 | 0.17052308 |
| 117 | TBK1 | 0.16779648 |
| 118 | PRKCQ | 0.16555302 |
| 119 | FER | 0.16068930 |
| 120 | CDK19 | 0.15377846 |
| 121 | MARK3 | 0.15342023 |
| 122 | PAK6 | 0.13764096 |
| 123 | ERBB3 | 0.13028421 |
| 124 | MAP2K7 | 0.12773371 |
| 125 | PRPF4B | 0.12619985 |
| 126 | JAK1 | 0.12203059 |
| 127 | EPHA3 | 0.12040105 |
| 128 | RPS6KA2 | 0.11996483 |
| 129 | PNCK | 0.11178214 |
| 130 | STK39 | 0.11174151 |
| 131 | KDR | 0.11028523 |
| 132 | MAPKAPK5 | 0.10617121 |
| 133 | CAMK2B | 0.10185645 |
| 134 | MAPK10 | 0.09605855 |
| 135 | PRKCA | 0.09502885 |
| 136 | TXK | 0.07676250 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.85560252 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.04957532 |
| 3 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.92167251 |
| 4 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.54643587 |
| 5 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.48954109 |
| 6 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.32196196 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.09595594 |
| 8 | Parkinsons disease_Homo sapiens_hsa05012 | 2.93130486 |
| 9 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.92933621 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.71391798 |
| 11 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.62586412 |
| 12 | Carbon metabolism_Homo sapiens_hsa01200 | 2.39346033 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.34086406 |
| 14 | Alzheimers disease_Homo sapiens_hsa05010 | 2.31316607 |
| 15 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.08515463 |
| 16 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.03961392 |
| 17 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.83976352 |
| 18 | Huntingtons disease_Homo sapiens_hsa05016 | 1.73157555 |
| 19 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.69991575 |
| 20 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.53854046 |
| 21 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.46464191 |
| 22 | Viral myocarditis_Homo sapiens_hsa05416 | 1.38777583 |
| 23 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.37018475 |
| 24 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.34296882 |
| 25 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.31509299 |
| 26 | Insulin resistance_Homo sapiens_hsa04931 | 1.30922374 |
| 27 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.27945274 |
| 28 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.24213566 |
| 29 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.19788364 |
| 30 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.13430247 |
| 31 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.10662024 |
| 32 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.09376807 |
| 33 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.07191871 |
| 34 | Circadian rhythm_Homo sapiens_hsa04710 | 1.06056687 |
| 35 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.04113349 |
| 36 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.01826496 |
| 37 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.99402544 |
| 38 | Phototransduction_Homo sapiens_hsa04744 | 0.94210058 |
| 39 | Galactose metabolism_Homo sapiens_hsa00052 | 0.91032011 |
| 40 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.90738350 |
| 41 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.87428228 |
| 42 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.86509197 |
| 43 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.85581876 |
| 44 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.83422322 |
| 45 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.82253694 |
| 46 | Insulin secretion_Homo sapiens_hsa04911 | 0.77370521 |
| 47 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.75975201 |
| 48 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.75626428 |
| 49 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.75039303 |
| 50 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.74209659 |
| 51 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.72477021 |
| 52 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.68855096 |
| 53 | ABC transporters_Homo sapiens_hsa02010 | 0.66861208 |
| 54 | Renin secretion_Homo sapiens_hsa04924 | 0.65881881 |
| 55 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.63367699 |
| 56 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.61846561 |
| 57 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.61389202 |
| 58 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.55220714 |
| 59 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.54319079 |
| 60 | Focal adhesion_Homo sapiens_hsa04510 | 0.54155572 |
| 61 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.54078283 |
| 62 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.52881390 |
| 63 | Lysine degradation_Homo sapiens_hsa00310 | 0.51010972 |
| 64 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.50395874 |
| 65 | GABAergic synapse_Homo sapiens_hsa04727 | 0.45739907 |
| 66 | Circadian entrainment_Homo sapiens_hsa04713 | 0.45059451 |
| 67 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.44786476 |
| 68 | Long-term depression_Homo sapiens_hsa04730 | 0.44592876 |
| 69 | Peroxisome_Homo sapiens_hsa04146 | 0.44137078 |
| 70 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.43889977 |
| 71 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.42651801 |
| 72 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.42549054 |
| 73 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.41741541 |
| 74 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.41695651 |
| 75 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.41317223 |
| 76 | Tight junction_Homo sapiens_hsa04530 | 0.40702493 |
| 77 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.40596748 |
| 78 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.39097744 |
| 79 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.37987124 |
| 80 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.37817309 |
| 81 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.37243542 |
| 82 | Purine metabolism_Homo sapiens_hsa00230 | 0.36997655 |
| 83 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.35139671 |
| 84 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.32686432 |
| 85 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.32200108 |
| 86 | Histidine metabolism_Homo sapiens_hsa00340 | 0.32185111 |
| 87 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.30218929 |
| 88 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.30007136 |
| 89 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.29295679 |
| 90 | Metabolic pathways_Homo sapiens_hsa01100 | 0.24166969 |
| 91 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.23603185 |
| 92 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.22485816 |
| 93 | Long-term potentiation_Homo sapiens_hsa04720 | 0.22266608 |
| 94 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.20807225 |
| 95 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.20154895 |
| 96 | Taste transduction_Homo sapiens_hsa04742 | 0.19987701 |
| 97 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.19187048 |
| 98 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.18624342 |
| 99 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.18550945 |
| 100 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.17370931 |
| 101 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.16991724 |
| 102 | Amoebiasis_Homo sapiens_hsa05146 | 0.15974815 |
| 103 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.15419218 |
| 104 | Olfactory transduction_Homo sapiens_hsa04740 | 0.15045344 |
| 105 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.15011590 |
| 106 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.14593339 |
| 107 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.14581474 |
| 108 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.14428528 |
| 109 | Salivary secretion_Homo sapiens_hsa04970 | 0.13684443 |
| 110 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.13408110 |
| 111 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.13000536 |
| 112 | Morphine addiction_Homo sapiens_hsa05032 | 0.12987114 |
| 113 | Platelet activation_Homo sapiens_hsa04611 | 0.12090031 |
| 114 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.11879773 |
| 115 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.11109622 |
| 116 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.09926195 |
| 117 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.09548571 |
| 118 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.09398194 |
| 119 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.09204819 |
| 120 | Adherens junction_Homo sapiens_hsa04520 | 0.08874884 |
| 121 | Gap junction_Homo sapiens_hsa04540 | 0.08679658 |
| 122 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.05836740 |
| 123 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.05063123 |

